Dinsmore & Shohl LLP’s Post

Big news for telehealth! The DEA is moving forward with plans to create a special telehealth registration for prescribers. This long-awaited initiative could significantly impact how healthcare providers deliver care remotely, especially for prescribing controlled substances. Why this matters: ✔️ Expands access to essential care for patients in underserved areas. ✔️ Streamlines regulatory processes for telehealth providers. ✔️ Opens doors for innovative telehealth solutions in compliance with federal regulations. As the demand for remote healthcare continues to grow, this move by the DEA could mark a major step toward ensuring equitable and secure access to care. #Telehealth #HealthcareInnovation #DigitalHealth #RegulatoryUpdates

Last week, we shared that the Drug Enforcement Administration (DEA) and the Department of Health and Human Services (HHS) released a proposed rule entitled, “Special Registrations for Telemedicine and Limited State Telemedicine Registrations.” This proposal would establish three Special Registrations that create a pathway for certain healthcare professionals to prescribe certain controlled substances via telemedicine. Here is a detailed summary of the proposal and the three special registration processes: https://lnkd.in/edQCDJKP #telehealth #virtualcare

DEA plans to create a special telehealth registration for prescribers - Healthcare IT news The DEA's proposed rulemaking introduces a special telehealth registration framework aimed at enhancing access to controlled substances while ensuring patient safety. This initiative follows the extension of pandemic-era virtual prescribing through 2025. The framework includes three registration types for clinicians and telemedicine platforms, addressing concerns about oversight and potential misuse. Industry leaders emphasize the need for careful implementation to avoid operational challenges and maintain patient access. As telehealth evolves, these updates could significantly impact the healthcare landscape. #Telehealth #HealthcareIT #DEA #PatientSafety #DigitalHealth #Telemedicine #RegulatoryCompliance ai.mediformatica.com #health #prescribing #controlledsubstances #acce #telehealth #healthcare #news #pandemic #healthcareit #safeguards #accetocare #best #digitalhealth #healthit #healthtech #healthcaretechnology @MediFormatica (https://buff.ly/3WqJ6xx)

DEA Proposes New Telehealth Prescribing Framework - DistilINFO Hospital IT The DEA's new telehealth prescribing framework introduces three registration categories for healthcare practitioners, enhancing the ability to prescribe controlled substances virtually. This includes core, advanced, and platform registrations, each tailored for specific needs. Compliance is key, with mandatory state registrations and electronic prescriptions following patient verification. Stricter guidelines for Schedule II medications require clinicians to be in the same state as patients. As the proposal aims to establish permanent rules post-pandemic, it balances accessibility with safety, addressing concerns around fraud prevention. This marks a pivotal shift in telehealth prescribing regulations. #Telehealth #HealthcareIT #DEA #Regulations #DigitalHealth #Telemedicine #PatientSafety ai.mediformatica.com #hospital #prescribing #telehealth #controlledsubstances #healthcare #telemedicine #telehealthprescribing #this #administration #physicians #platform #advanced #digitalhealth #healthit #healthtech #healthcaretechnology @MediFormatica (https://buff.ly/3E4WqkR)

🚨 This blog is an update on the DEA telemedicine controlled substance prescribing flexibilities, with links on how you can help the effort. Please read and re-share to SPREAD THE WORD. 🚨 With insufficient time before the end of the year to enact a special registration rule, the only path forward to avoid the Telehealth Cliff is to extend the flexibilities further. This will allow time for the DEA to draft a new proposed rule (ideally doing so in collaboration with a taskforce comprised of practicing clinicians and industry stakeholders). Without an extension, the flexibilities that have increased access to health care for individuals in rural and underserved communities over the past four years will disappear after December 31, 2024, and thousands of patients will lose access to critical medications. #telemedicine #telehealth #digitalhealth #DEA #HLTH American Telemedicine Association ATA Action Alliance for Connected Care CTeL Center for Connected Health Policy Foley & Lardner LLP Scott Brinks Marika Miller Kyle Zebley Joanna Strober Krista Drobac

In the wake of the Drug Enforcement Administration's notice of a forthcoming rule with a third extension of flexibilities on telemedicine prescribing of controlled substances, some stakeholders anticipate DEA will extend the current flexibilities for 1-2 years to avoid the Telehealth Cliff. The rule is expected to be released soon and become available for public review. In this recent episode of the Health & Hype podcast, Rafid Fadul, MD, MBA and I explore the latest updates on DEA regulations, the future of telemedicine, and how health systems, hospitals, and startups can innovate while staying compliant. Click the link below for a summary and to listen to our discussion. #telemedicine #telehealth #digitalhealth #DEA #controlledsubstances #ATA #ATAEDGE American Telemedicine Association ATA Action Foley & Lardner LLP Zivian Health

DEA and the Department of Health and Human Services (HHS) has extended current telemedicine (TM) flexibilities through end 2025. MDs may Rx meds via TM (including narcotics) without in-office visits.

As of June 2024, a DEA proposed rule regarding telehealth prescribing of controlled substances has reached the White House for review. This review is the final step before the proposal can be released to the public. Check out our latest blog to learn what we know so far about this ruling. Read more here: https://lnkd.in/dP-Gbjjb #DEA #controlledsubstances #telehealth #ePrescribing

With the DEA extending telemedicine prescription rules for Schedule II-V controlled substances through 2025, healthcare professionals have more time to adapt and innovate in delivering virtual care. Explore the legal and operational implications in Garfunkel Wild, P.C.'s article: https://bit.ly/4gDLbhm #Telemedicine #Healthcare

The DEA & DHHS issued a third extension of telemedicine flexibilities for prescribing controlled medications through 12/31/2025. This policy allows continued and expanded treatment for and helps reduce the risk for overdose and complications of misuse.  https://lnkd.in/eQP4xZYR